Date: December 24, 2018
Jamaican Teas Limited (JAMT) reported a 14% increase in revenues to total $1.77 billion (2017: $1.55 billion). For the quarter, revenues amounted to $422.12 million (2017: $357.64 million). JAMT highlighted that, “the Company’s focus on driving revenues in our core business resulted in fourth quarter revenues from our manufacturing operations growing 20 percent for both exports and domestic sales. Supermarket sales increased by 9 percent.”
JAMT further indicated that, “For the year, export sales increased by a strong 24 percent, domestic manufacturing revenues grew 12 percent and supermarket revenues rose 6 percent. The growth in exports in 2017/8 exceeded the average rate of export growth of almost 17 per cent in US$ experienced in the eight preceding years.”
Cost of sales increased by 17% to $1.43 billion (2017: $1.22 billion). As a result, gross profit grew 2% to $337.61 million (2017: $330.16 million). For the quarter, gross profit closed at $73.05 million relative to $87.39 million reported in the previous corresponding quarter. The company mentioned that, “The improved sales results experienced in the quarter are not reflected in the Group’s gross profits which were flat, primarily as a result of a $15 million profit deterioration at H Mahfood and Sons Ltd arising from increased construction and remediation costs incurred to finish the Orchid Estates housing development.”
Other income increased slightly by 2% to $106.17 million versus $104.42 million in the prior year. Within the quarter, other income rose by 1% to close at $44.41 million (2017: $44.15 million).
Administrative expenses increased by 3% to $180.73 million for the year ended September 2018 relative to $175.14 million for the same period of 2017. Sales and Marketing costs went up by 14% totaling $42.31 million (2017: $37 million). For the quarter administrative expenses and sales & marketing costs closed at $50.07 million (2017: $54.74 million) and $4.05 million (2017: $11.74 million), respectively.
Finance cost for the year amounted to $18.75 million relative to $24.61 million reported in 2017.
Pre-tax profits fell by 7% for the year end, decreasing from $219.16 million in 2017 to $202.85 million. JAMT incurred tax expenses of $9.59 million compared to $23.03 million during the 2017 comparable period. For the quarter, pretax profit amounted to $59.70 million (2017: $53.78 million). The Company indicated that, “this increase was primarily because of lower borrowing costs and the elimination of losses at Bay City Foods Ltd, our associated company.”
Net profit for the year contracted 1% to $193.26 million relative to $196.13 million recorded twelve months earlier. Profit for the fourth quarter rose 33% to close at $60.68 million (2017: $45.47 million). JAMT stated that, “Net profit for the year is lower than the prior year primarily due to the non-recurrence of the $29 million gain on the acquisition of KIW reported last year but not repeated this year.”
However, for the year net profit attributable to shareholders climbed slightly by 2% to close the period at $198.55 million (2017: $194.59 million). While for the quarter, net profit attributable to shareholders went up by 53% totaling $66.88 million compared to $43.63 million in the prior comparable quarter.
Consequently, earnings per share totaled $0.289 compared to $0.284 for the year ended September 30, 2018, while for the quarter, the EPS was $0.097 (2017: $0.064). The numbers of shares used in the calculations are 686,033,460 units. JAMT last traded on December 21, 2018 at $3.90.
Balance Sheet at a glance:
As at September 2018, the Company total assets amounted to $1.74 billion, an increase of 12% when compared to the $1.55 billion reported as at September 2017. This growth was driven primarily by 103% growth in ‘Investments’ from $227.36 million in 2017 to $461.74 million for the period under review.
Shareholders’ Equity totalled $1.25 billion as at September 30, 2018 (2017: $1.06 billion), resulting in a book value per share of $1.82 (2017: $1.55).
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.